CA
NZ
UK
AU
IND
US
Costco’s Strategic Entry into Medicare
Intelligent Bio Solutions Inc. (NASDAQ: INBS) reported its financial results for the fiscal year ending June 30, 2026, achieving total revenue of $4.2 million. This figure represents a strong 38% increase compared to the previous year’s revenue of approximately $3.05 million. The surge in …
AbbVie Inc. (NYSE: ABBV) has successfully completed a $500 million public offering of senior notes to enhance its financing capabilities for the acquisition of Apogee Therapeutics, Inc. The offering includes various classes of notes, featuring both floating and fixed interest rates, reflecting AbbVie's strategic …
Each holder of Coherus Oncology, Inc. (NASDAQ: CHRS)'s common stock,Par Value$0.0001, will receive one CVR for every share they own as of the record date. This move is aimed at offering stockholders a potentialRevenuestream linked to the future performance of the company’s remaining biosimilar …
Earth Science Tech, Inc. (OTC: ETST) has successfully completed the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients located in Doral, Florida. This strategic acquisition not only secures a vital addition to ETST’s supply chain but also positions the company for …
Kiora Pharmaceuticals has finalized a licensing agreement with Chong Kun Dang Pharmaceutical Corporation (CKD), granting exclusive rights to commercialize its KIO-301 product in South Korea. The deal includes an immediate payment of $1 million and positions Kiora to tap into a significant market for …
Nuo Therapeutics, Inc. (OTC: AURX) reported a substantial increase in revenue, achieving approximately $1.77 million for the second quarter ending June 30, 2026. This figure represents more than a 150% increase from revenues recorded in the same quarter of 2025. Stronger performance in both …
Oxford Nanopore Technologies PLC (OTC: ONTTF), a company operating in the biotechnology sector with a marketCapitalizationof $1.61 billion, reported first-half revenue of £116.7 million, reflecting a 12.3% increase at constant currency. However, this figure fell short of analyst expectations as it faced challenges from …
Teva Pharmaceuticals announced a significant milestone with the FDA's acceptance of itsNew Drug Application (NDA)for ecopipam, targeting pediatric patients suffering from Tourette syndrome. This acceptance, supported by positive Phase 3 trial data, highlights the drug's effectiveness in reducing tic severity and fulfilling an urgent …
Moderna (NASDAQ: MRNA) shares catapulted 90% in trading today following positive late-stage clinical trial results for its experimental cancer vaccine developed inPartnershipwith Merck. The combination regimen, targeting melanoma, demonstrated a significant extension in the time patients lived without their cancer returning, offering a material …
Please wait processing your request...